Last deal

Amount

Venture - Series Unknown

Stage

01.10.2015

Date

2

all rounds

date founded

Financing round

General

About Company
GPCR Therapeutics USA is a biotechnology company that develops innovative therapeutics targeting cancer.

Industry

Sector :

Subsector :

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company, originating from GPCR Therapeutics Inc. in Korea, is focused on discovering and developing cancer treatments using its GPCR heteromer science. Their most advanced clinical candidate, Burixafor, is set to begin a US clinical trial next year, with a specific focus on the CXCR4 heteromer hypothesis. GPCR Therapeutics also plans to identify key GPCR heteromers as therapeutic targets in oncology. Led by Dr. Pina Cardarelli, the team of researchers will expand in the coming years to further their mission of addressing unmet medical needs in cancer treatment.
Contacts

Social url

Similar Companies
1000
ImmunOs Therapeutics

ImmunOs Therapeutics

ImmunOs Therapeutics is a clinical-stage biotech developing novel human immunomodulatory proteins for cancer and autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

8952 Schlieren, Switzerland

total rounds

6

total raised

$75.04M
Neon Therapeutics

Neon Therapeutics

Neon Therapeutics develops personalized vaccines and autologous T-cell therapies for cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

total rounds

3

total raised

$161M
Ziopharm oncology

Ziopharm oncology

ZIOPHARM Oncology is a biotechnology company developing gene therapy, cell therapy, and cancer immunotherapy products.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

New York, NY, USA

total rounds

9

total raised

$293.39M
Compass Therapeutics, Inc.

Compass Therapeutics, Inc.

Compass Therapeutics is a biopharmaceutical company that develops antibody therapeutics to treat human diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Boston, MA, USA

total rounds

9

total raised

$381.51M

Financials

Funding Rounds
2
2

Number of Funding Rounds

Their latest funding was raised on 01.10.2015. Their latest investor TIPS Program. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
01.10.2015
1
01.01.2015
1
Co-Investors
Investors
2
0

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 
No
Venture - Series Unknown
No
Venture - Series Unknown
TIPS Program

TIPS Program

TIPS is a tech start-up support system that chooses private sector-led teams with technological items.

Sector

Software and Computer Services

Subsector

Computer Services

Keywords

Information Technology, Software

Location

Gangneung-si, Gangwon-do, South Korea

count Of Investments

1135

count Of Exists

9
Capstone Partners Co., Ltd.

Capstone Partners Co., Ltd.

Capstone Partners is a venture capital firm investing in early-stage companies in innovative tech industries.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

Seoul, South Korea

count Of Investments

268

count Of Exists

18

Activity

Recent News
1